Array BioPharma (NASDAQ: ARRY) announced today that it has appointed Andrew Robbins to the position of Senior Vice President of Commercial Operations. The creation of this new position reflects the ...

As of Wednesday, February 25, Array Technologies, Inc.’s ARRY share price has surged by 5.22%, which has investors questioning if this is right time to sell.

Array issues 2026 guidance CHICAGO, Feb. 20, 2026 /PRNewswire/ -- As previously announced, Array will hold a teleconference on February 20, 2026, at 9:00 a.m. CST.

CHICAGO, Aug. 1, 2025 /PRNewswire/ -- Array Digital Infrastructure, Inc. SM ("Array SM "), (NYSE: USM), formerly United States Cellular Corporation, has declared a special cash dividend of $23.00 per ...